航天科技(000901.SZ):一季度淨利預降38.95%-59.30%
格隆匯4月15日丨航天科技(000901.SZ)披露2022年第一季度業績預吿,預計2022年第一季度實現歸屬於上市公司股東的淨利潤為800萬元-1200萬元,同比下降38.95%-59.30%;扣除非經常性損益後的淨利潤為400萬元-600萬元,同比下降57.87%-71.91%。主要原因系:
境外汽車電子業務訂單因新冠疫情、芯片供應短缺等影響導致訂單交付延遲;同時,歐美國家通貨膨脹壓力,導致人工成本、物流及能源等費用上漲,另外,抗疫支持補貼減少,從而導致公司淨利潤有所下滑。由於境內部分客户所在地區新冠疫情管控,境內汽車電子業務訂單部分暫時減少或延遲交付,影響該部分業務營業收入。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.